The Patent Finder

Atrogi AB

11 patents currently held · Updated Nov 21, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Dec 2033
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Apr 24, 2027
    The maintenance fee for Chiral beta-hydroxyethylamines and their use in the treatment of hyperglycemia (US 11,793,774) comes due Apr 24, 2027. Unpaid by Oct 25, 2027, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,891,212Screening method, a kit, a method of treatment and a compound for use in a method of treatment
In force
 · USPTO record
In forceUSPTO record
US 9,784,726Screening method, a kit, a method of treatment and a compound for use in a method of treatment
In force
 · USPTO record
In forceUSPTO record
US 10,288,602Screening Method, a Kit, A method of Treatment and a Compound for Use in a Method of Treatement
In force
 · Medium confidence
In forceMedium confidence
US 9,657,348Method of screening compounds for the treatment of diabetes
In force
 · USPTO record
In forceUSPTO record
US 11,357,757Heteroaryl Substituted Beta-Hydroxyethylamines for Use in Treating Hyperglycaemia
In force
 · High confidence
In forceHigh confidence
US 11,427,539Beta-hydroxy heterocyclic amines and their use in the treatment of hyperglycaemia
In force
 · USPTO record
In forceUSPTO record
US 12,280,023Fluorophenyl Beta-Hydroxyethylamines and Their Use in the Treatment of Hyperglycaemia
In force
 · Medium confidence
In forceMedium confidence
US 11,648,216Fluorophenyl Beta-Hydroxyethylamines and Their Use in the Treatment of Hyperglycaemia
In force
 · High confidence
In forceHigh confidence
US 11,793,774Chiral beta-hydroxyethylamines and their use in the treatment of hyperglycemia
In force
 · USPTO record
In forceUSPTO record
US 12,036,210Heteroaryl Substituted Beta-Hydroxyethylamines for Use in Treating Hyperglycaemia
In force
 · High confidence
In forceHigh confidence
10 of 11 patents shown.
Pro members see all 11.
Pro members: see all 11 patents

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

7 pending · 7 no status recorded

Showing 1 to 10 of 14, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.

ApplicationTitleFiledStatus
18/678,103Heteroaryl Substituted Beta-Hydroxyethylamines for Use in Treating HyperglycaemiaMay 30, 2024Pending
18/858,544Combinations of Beta 2-ADRENERGIC Receptor Agonists and Beta 3-ADRENERGIC Receptor Agonists, and Medical Uses ThereofApr 21, 2023Pending
18/848,949Mar 23, 2023No status recorded
18/717,134Crystalline Form of (R)-2-(TERT-BUTYLAMINO)-1-(5-FLUOROPYRIDIN-3-YL)-ETHAN-1-OL Hemi-Tartrate Salt for the Treatment of Hyperglycemia and Diabetes 2Dec 9, 2022Pending
18/693,573Substituted Hydroxymethyl Pyrrolidines and Medical Uses ThereofSep 23, 2022Pending
18/693,571Cyclohexyl Beta-Hydroxy Alkyl Amines and Medical Uses ThereofSep 23, 2022Pending
18/027,890Sep 23, 2021No status recorded
18/027,888ARYLAZABICYCLO[21.1]HEXYLMETHANOLS Derivatives and Medical Uses ThereofSep 23, 2021Pending
17/320,774May 14, 2021No status recorded
16/908,312Jun 22, 2020No status recorded
10 of 14 applications shown.
Pro members see all 14 published applications.
Pro members: see all 14 applications
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited